Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)

NCT04589299 PHASE4 RECRUITING

SIDEC - (Subcutaneous Immunoglobulin in De-novo CIDP) ia a study designed as a randomized, parallel study with an open-label extension phase. The aims are to compare the effect of SCIG and IVIG in 60 treatment-naïve CIDP patients, and to detect the lowest effective dosage for maintenance treatment.

Details

Lead sponsor	University of Aarhus
Phase	PHASE4
Status	RECRUITING
Enrolment	60
Start date	Thu Jun 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Dec 31 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Interventions

• Immunoglobulin

Countries

Denmark